Global Serum Free Media Market Research 2024, Forecast To 2033
8 Mar, 2024
Serum-free media market escalated from $1.45 billion in 2023 to $1.63 billion in 2024, growing at 12.3% CAGR due to cell culture advancements. Expected growth to $2.49 billion in 2028 (CAGR: 11.1%) is attributed to bioprocessing expansion and stem cell research. Trends encompass technological innovations and animal component-free solutions.
Global Serum Free Media Market Key Driver
The serum-free media market is expanding due to the increasing prevalence of chronic diseases, projected to affect 142.66 million individuals aged 50 years and older by 2050. Serum-free media enables optimal cell growth conditions, essential for research and development of therapies for chronic illnesses, driving the demand for advanced cell culture technologies.
Get A Free Sample Of The Global Serum Free Media Market ReportGlobal Serum Free Media Market Segments
The serum free media market covered in this report is segmented –
1) Media Type:Chinese Hamster Ovary (CHO) Cell Media, Protein Expression Media, Immunology Media, Insect Cell Media, Hybridoma Media, Stem Cell Media, Chemically Defined Media
2) Application:Biopharmaceutical Production, Tissue Engineering And Regenerative Medicine
3) End-User:Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Centers, Other End-Users
By Geography: The countries covered in the serum free media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the serum-free media market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum free media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Serum Free Media Industry Players
Thermo Fisher Scientific Inc.; Danaher Corp.; Merck KgaA; FUJIFILM Irvine Scientific Inc.; GE HealthCare Technologies Inc.; Corning Inc.; Lonza Group AG; Illumina Inc.; Cytiva; Sigma-Aldrich; Bio-Techne Corporation; Serumwerk Bernburg AG; STEMCELL Technologies Inc.; MP Bio medicals LLC; Gemcell Electrical Group.; InVitria Inc.; Takara Bio Inc.; HiMedia Laboratories Pvt. Ltd.; PAA Laboratories GmbH; PromoCell GmbH; Cellgenix Gmbh; Biochrom AG; Biological Industries; Pan Biotech GmbH; Biowest SAS; Bovogen Biologicals Pty Ltd; Athena Environmental Sciences Inc.; Cell Culture Technologies LLC.; BioSpherix Ltd.; ZenBio Inc.
Get The Full Global Serum Free Media Market Report
Serum Free Media Market Overview
Serum-free media is a type of cell culture media that allows cells to be cultured without animal sera. Serum-free media is used in cell culture to reduce the risk of contamination and to provide better control over the physiological responsiveness of the cells.